Global Cord Blood Corporation - stock earnings
Stock symbol CO is outdated, potentially delisted? Maybe it is available on other exchange?
CO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q1 | 104.7 million USD | 297.2 million USD |
| 2021Q4 | 134.2 million USD | 317.2 million USD |
| 2021Q3 | 125.7 million USD | 313.7 million USD |
| 2021Q2 | 136.4 million USD | 315.2 million USD |
| 2021Q1 | 127.7 million CNY | 302.3 million CNY |
| 2020Q4 | 116.6 million CNY | 290.8 million CNY |
| 2020Q3 | 131.4 million CNY | 285.6 million CNY |
| 2020Q2 | 132.5 million CNY | 280.9 million CNY |
CO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 501.1 million USD | 1.2 billion USD |
| 2021 | 508.2 million USD | 1.2 billion USD |
| 2020 | 470.7 million USD | 1.2 billion USD |
| 2019 | 291.1 million USD | 986.8 million USD |
| 2018 | 237.1 million CNY | 936.8 million CNY |
CO
Price: $2.99
52 week price:
Dividend Yield: 3.42%
Payout Ratio Range:
Earnings Per Share: 0.58 USD
P/E Ratio: 5.06
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 7
Ebitda: 35.1 millionMarket Capitalization: 400.1 million